Status:
TERMINATED
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Lead Sponsor:
Abiomed Inc.
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18-90 years
Phase:
PHASE3
Brief Summary
This is a randomized trial investigating the use of the IMPELLA RECOVER LP 2.5 compared to Intra-aortic balloon pump (IABP) in patients with Acute Myocardial Infarction.
Eligibility Criteria
Inclusion
- Informed Consent
- Subject presenting with STEMI undergoing primary PCI
- Patient presents with at least 1 of the following:
- Unstable blood pressure
- Tachycardia and tissue hypoperfusion
- The need for intravenous pressor or inotropic support
- Patient presents with STEMI:
- CK-MB\>2x normal
Exclusion
- Unwitnessed cardiac arrest
- Abnormalities of the aorta
- Recent stroke or TIA
- Mural thrombus in the left ventricle
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00972270
Start Date
July 1 2008
End Date
September 1 2010
Last Update
March 21 2011
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Hospital
Hartford, Connecticut, United States, 06102
2
University of Chicago Medical Center
Chicago, Illinois, United States, 60637
3
Shawnee Mission
Shawnee Mission, Kansas, United States, 66204
4
Valley Hospital
Hawthorne, New Jersey, United States, 07506